Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

Anti-SARS-CoV-2 antibody dynamics after primary vaccination with two-dose inactivated whole-virus vaccine, heterologous mRNA-1273 vaccine booster, and Omicron breakthrough infection in Indonesian health care workers.

Suwarti S. et al, (2024), BMC Infect Dis, 24

The effect of pH on the structure of Bluetongue virus VP5.

Zhang H. et al, (2024), J Gen Virol, 105

Immunogenicity of Abdala COVID-19 vaccine in Vietnamese people after primary and booster vaccinations: a prospective observational study in Vietnam.

Thanh TT. et al, (2024), Int J Infect Dis

The impact of exchanging the light and heavy chains on the structures of bovine ultralong antibodies.

Clarke JD. et al, (2024), Acta Crystallogr F Struct Biol Commun, 80, 154 - 163

Improving the representativeness of UK's national COVID-19 Infection Survey through spatio-temporal regression and post-stratification.

Pouwels KB. et al, (2024), Nat Commun, 15

A structure-function analysis shows SARS-CoV-2 BA.2.86 balances antibody escape and ACE2 affinity.

Liu C. et al, (2024), Cell Rep Med, 5

Emerging variants develop total escape from potent monoclonal antibodies induced by BA.4/5 infection.

Liu C. et al, (2024), Nat Commun, 15

The SARS-CoV-2 neutralizing antibody response to SD1 and its evasion by BA.2.86.

Zhou D. et al, (2024), Nat Commun, 15

Risk of SARS-CoV-2 reinfection during multiple Omicron variant waves in the UK general population.

Wei J. et al, (2024), Nat Commun, 15

Emerging Enterovirus A71 Subgenogroup B5 Causing Severe Hand, Foot, and Mouth Disease, Vietnam, 2023.

Chau NVV. et al, (2024), Emerg Infect Dis, 30, 363 - 367

Southeast Asia initiative to combat SARS-CoV-2 variants (SEACOVARIANTS) consortium.

Nhu LNT. et al, (2024), Wellcome Open Res, 9

Delayed mucosal anti-viral responses despite robust peripheral inflammation in fatal COVID-19.

Sidhu JK. et al, (2023), J Infect Dis

Para-infectious brain injury in COVID-19 persists at follow-up despite attenuated cytokine and autoantibody responses.

Michael BD. et al, (2023), Nat Commun, 14

Structural comparison of typical and atypical E2 pestivirus glycoproteins.

Aitkenhead H. et al, (2023), Structure

Quantifying neutralising antibody responses against SARS-CoV-2 in dried blood spots (DBS) and paired sera

Roper KJ. et al, (2023), Scientific Reports, 13

COVID-19 therapeutics: stewardship in England and considerations for antimicrobial resistance.

Bou-Antoun S. et al, (2023), J Antimicrob Chemother, 78, ii37 - ii42

Persistence of SARS-CoV-2 antibodies over 18 months following infection: UK Biobank COVID-19 Serology Study.

Bešević J. et al, (2023), J Epidemiol Community Health

ChAdOx1 COVID vaccines express RBD open prefusion SARS-CoV-2 spikes on the cell surface.

Ni T. et al, (2023), iScience, 26

Experimental phasing opportunities for macromolecular crystallography at very long wavelengths.

El Omari K. et al, (2023), Commun Chem, 6

Accelerating drug target inhibitor discovery with a deep generative foundation model.

Chenthamarakshan V. et al, (2023), Sci Adv, 9

Load More

Include forthcoming?